News
Sanofi will exit consumer health and boost R&D investment
Sanofi is following in the footsteps of a number of its peers in …
19787 items found
R&D
On a journey to diverse, inclusive, and more efficient rare disease trials
Although orphan drugs represent a sizeable portion of new drug …
R&D
Evolving with the patient: Optimising CAGT post-trial long-term follow-up
The tremendous growth in cell and gene therapy is no surprise to the …
News
COVID, flu combo jab from Pfizer/BioNTech heads for phase 3
A combination COVID-19 and influenza vaccine being developed by …
News
China clears ViiV, J&J injectable HIV treatment
ViiV Healthcare and Johnson & Johnson have been granted approval in …
News
NICE backs pump-based Parkinson’s drug from AbbVie
A therapy for Parkinson’s disease that can be delivered by a 24-hour …
News
First data with subcutaneous Leqembi, and other CTAD news
Eisai and Biogen have reported data showing that a subcutaneous …
R&D
The longitudinal history of medicines innovation: Part One
As we move forwards in public discussions on pharmaceutical …
News
Sofinnova raises $200m for digital medicine fund
Life sciences venture capital company Sofinnova has doubled down on …
Patients
How to leverage real-world data for better patient care
Real-world data (RWD) creates exciting new opportunities to improve …
News
BioXcel shares rise on result of Alzheimer’s drug probe
Shares in BioXcel Therapeutics rose more than 31% in early trading …
Patients
Why medical weight loss is more complicated than GLP-1s
A few weeks ago on the pharmaphorum podcast, we discussed the new …
News
Incyte blocks US launch of Sun Pharma's alopecia drug
A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata.
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Europe’s Largest Industry-Led & Dedicated Gathering for mRNA...
The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to showcasing the hottest disease targets,
R&D
Partner Content
Proteomic Based Drug Discovery Summit 2025
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
